Skip Navigation LinksHome > August 2008 - Volume 46 - Issue 8 > Selecting High Priority Quality Measures For Breast Cancer Q...
Medical Care:
doi: 10.1097/MLR.0b013e318178ead3
Original Article

Selecting High Priority Quality Measures For Breast Cancer Quality Improvement

Hassett, Michael J. MD, MPH*; Hughes, Melissa E. MSc*; Niland, Joyce C. PhD†; Ottesen, Rebecca MS†; Edge, Stephen B. MD‡; Bookman, Michael A. MD§; Carlson, Robert W. MD¶; Theriault, Richard L. DO, MBA∥; Weeks, Jane C. MD, MSc*

Collapse Box

Abstract

Background: Although many quality measures have been created, there is no consensus regarding which are the most important. We sought to develop a simple, explicit strategy for prioritizing breast cancer quality measures based on their potential to highlight areas where quality improvement efforts could most impact a population.

Methods: Using performance data for 9019 breast cancer patients treated at 10 National Comprehensive Cancer Network institutions, we assessed concordance relative to 30 reliable, valid breast cancer process-based treatment measures. We identified 4 attributes that indicated there was room for improvement and characterized the extent of burden imposed by failing to follow each measure: number of nonconcordant patients, concordance across all institutions, highest concordance at any 1 institution, and magnitude of benefit associated with concordant care. For each measure, we used data from the concordance analyses to derive the first 3 attributes and surveyed expert breast cancer physicians to estimate the fourth. A simple algorithm incorporated these attributes and produced a final score for each measure; these scores were used to rank the measures.

Results: We successfully prioritized quality measures using explicit, objective methods and actual performance data. The number of nonconcordant patients had the greatest influence on the rankings. The highest-ranking measures recommended chemotherapy and hormone therapy for hormone-receptor positive tumors and radiation therapy after breast-conserving surgery.

Conclusions: This simple, explicit approach is a significant departure from methods used previously, and effectively identifies breast cancer quality measures that have broad clinical relevance. Systematically prioritizing quality measures could increase the efficiency and efficacy of quality improvement efforts and substantially improve outcomes.

© 2008 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.